Test anti-tumor and anti-metastatic drug efficacy in a large number of PDX models to select those with the best chance for success in subsequent mouse studies.
ZTX™ ONCOLEADS accurately predicts the metastatic potential of PDX models and thereby provides insights into the anti-metastatic efficacy of drug candidates.
Design customized PDX trials including different patient groups or sub-groups to find those with the highest chance of exhibiting superior drug response.
Combine your drug candidate with standard care treatments and identify the groups of patients with the highest efficacy.
Ask your questions or request an introductory call.